NCT04337970 2025-05-28Talazoparib and Axitinib for People With Previously Treated Advanced Kidney CancerMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed23 enrolled
NCT04068831 2024-12-27Talazoparib and Avelumab in Participants With Metastatic Renal Cell CarcinomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed18 enrolled 9 charts